Come up with a name for your new list and we'll add to it:
CuroNZ raised a round of funding on October 14, 2013. Investors include
Multiple Sclerosis Society of New Zealand.
CuroNZ is a small Biotechnology start-up company with a drug patent portfolio covering the peptide family, Neural Regeneration Peptides (NRPs). The company plans to develop our drug to the end of pre…